ABS0659 DEVELOPMENT OF THE DEUS ENTHESITIS INDEX (DEI): A COMPREHENSIVE TOOL INTEGRATING ULTRASOUND AND PHYSICAL EXAMINATION FINDINGS FOR ENTHESITIS ASSESSMENT IN SPONDYLOARTHRITIS

末端炎 医学 体格检查 轴性脊柱炎 物理疗法 强直性脊柱炎 外科 内科学 关节炎 骶髂关节炎 银屑病性关节炎
作者
Andrea Di Matteo,Stefano Di Donato,E. Filippucci
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:84: 2133-2134
标识
DOI:10.1016/j.ard.2025.06.1752
摘要

Background: Enthesitis, characterized by inflammation at the sites where tendons, ligaments, or joint capsules insert into bone, is a key hallmark of spondyloarthritis (SpA), encompassing both axial SpA (axSpA) and psoriatic arthritis (PsA). Its accurate assessment is essential for effective diagnosis, management, and monitoring of disease activity and treatment response. However, traditional assessment methods relying primarily on physical examination are hindered by low specificity, underscoring the limitations of this approach in reliably evaluating enthesitis [1]. While ultrasound offers greater accuracy by detecting subclinical inflammation, it does not provide a complete picture of the pathology or its impact on patient symptoms and functional status when used in isolation. To bridge this gap, the DEUS Enthesitis Index (DEI) was developed as a novel scoring system that integrates the strengths of both ultrasound and physical examination into a unified, comprehensive tool. Objectives: 1To developed a composite score, the DEUS Enthesitis Index, incorporating ultrasound-detected active enthesitis and clinical examination findings. 2To evaluate the correlation of DEI with established SpA disease activity indices, patient-reported outcomes, and structural damage detected on ultrasound. 3To compare the performance of DEI against the Leeds Enthesitis Index (LEI), a widely used clinical tool for assessing enthesitis. Methods: A cross-sectional, multicentric study involving 20 rheumatology centers across 11 countries recruited 413 SpA patients (224 axSpA, 189 PsA). Exclusion criteria included recent lower limb trauma or surgery, intense physical activity in the two weeks before enrolment, or fibromyalgia. Bilateral assessment of five lower limb entheseal sites—quadriceps tendon, proximal and distal patellar tendons, Achilles tendon, and plantar fascia—was performed using standardized physical examination and ultrasound protocols. DEI scores were calculated by assigning 1.0 for clinical enthesitis (tenderness upon pressure, mobilization, or contraction against resistance, with or without swelling at the enthesis) and 1.0 for ultrasound-detected active enthesitis as previously defined by our group [2], yielding a maximum score of 20 per patient. Regression analyses evaluated correlations between DEI and disease activity indices (ASDAS, BASDAI, DAPSA), CRP levels, patient-reported outcomes (HAQ, VAS pain), and ultrasound-detected structural damage (enthesophytes, bone erosions). Model performance was compared using Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC). Results: The median DEI among SpA patients was 1.0 (interquartile range: 0.0–3.0). Higher DEI values were observed at the Achilles tendon enthesis compared to other sites, underscoring the importance of this entheseal site in SpA clinical manifestations. DEI correlated significantly with markers of axSpA disease activity, including ASDAS (rho=0.386), BASDAI (rho=0.402), and CRP levels (rho=0.117, p=0.018). In contrast, no correlation was observed between DEI and DAPSA values, emphasizing the distinct domains of joint and entheseal involvement in SpA. Strong associations were observed between DEI and with patient-reported outcomes, including VAS global pain (rho=0.303, p<0.001), HAQ (rho=0.294, p<0.001) and with structural damage identified on ultrasound (enthesophytes, OR=1.58, 95% CI: 1.34–1.94; bone erosions, OR=1.35, 95% CI: 1.19–1.54; both p<0.001). Compared to the LEI, DEI values demonstrated significantly stronger correlations with C-reactive protein levels and a more robust association with ultrasound-detected structural damage at the enthesis, including enthesophytes and bone erosions. Conversely, LEI scores exhibited significantly stronger correlations with indices of SpA disease activity. A comparison of DEI and LEI models across various disease outcomes in SpA patients is presented in Table 1. Conclusion: The DEUS Enthesitis Index (i.e., DEI) represents a novel, integrative tool that combines the sensitivity of physical examination with the specificity of ultrasound to provide a comprehensive assessment of enthesitis in SpA. Its strong correlations with objective inflammatory markers and structural damage highlight its potential utility in clinical practice and research settings. Future longitudinal studies are warranted to assess its responsiveness to treatment and predictive value for long-term outcomes. REFERENCES: [1] Helliwell PS. Assessment of Enthesitis in Psoriatic Arthritis. J Rheumatol. 2019. [2] Di Matteo A, et al. Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study. Ann Rheum Dis. 2024. Table 1. Comparison of for DEI and LEI models across various disease outcomes in SpA patients, all the models are adjusted for age and sex. Acronyms. ASDAS : Ankylosing Spondylitis Disease Activity Score. axSpA: axial spondyloarthritis. BASDAI : Bath Ankylosing Spondylitis Disease Activity Index. CI : confidence interval. CRP : C-reactive protein. DAPSA : Disease Activity in Psoriatic Arthritis. DEI : DEUS enthesitis index. HAQ : Health Assessment Questionnaire Disability-Index. LEI : Leeds Enthesitis Index. PsA : psoriatic arthritis. SpA : spondyloarthritis. US : ultrasound. VAS : Visual Analogue Scale. Acknowledgements: NIL . Disclosure of Interests: Andrea Di Matteo Janssen, Stefano Di Donato: None declared , Emilio Filippucci AbbVie, Amgen, BMS, Janssen, Lilly, Novartis, Pfizer and Union Chimique Belge Pharm. © The Authors 2025. This abstract is an open access article published in Annals of Rheumatic Diseases under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Neither EULAR nor the publisher make any representation as to the accuracy of the content. The authors are solely responsible for the content in their abstract including accuracy of the facts, statements, results, conclusion, citing resources etc.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
2秒前
TreKex完成签到,获得积分10
3秒前
Lonze完成签到,获得积分10
3秒前
李沅翰完成签到,获得积分10
5秒前
泰想成功发布了新的文献求助10
5秒前
可爱的函函的应助被WT采纳,获得10
5秒前
xnyscmbs完成签到 ,获得积分20
5秒前
5秒前
5秒前
Bruce完成签到,获得积分10
6秒前
凝夜发布了新的文献求助10
6秒前
Prospect发布了新的文献求助10
7秒前
9秒前
10秒前
直率翠绿发布了新的文献求助10
10秒前
科研通AI6.4的应助被可爱采纳,获得10
10秒前
11秒前
孟语佳完成签到,获得积分10
11秒前
11秒前
12秒前
张伟发布了新的文献求助10
13秒前
13秒前
13秒前
13秒前
努力的宁完成签到,获得积分10
14秒前
布鲁鲁完成签到,获得积分10
14秒前
cyx发布了新的文献求助10
14秒前
ZIYUNI完成签到 ,获得积分10
16秒前
16秒前
cdercder的应助被皮卡丘采纳,获得10
17秒前
17秒前
Spice完成签到 ,获得积分10
18秒前
18秒前
FashionBoy的应助被leo采纳,获得10
18秒前
充电宝的应助被Prospect采纳,获得10
19秒前
lianmeiliu发布了新的文献求助10
19秒前
21秒前
yinyinyin发布了新的文献求助10
22秒前
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188221
求助须知:如何正确求助?哪些是违规求助? 9576025
关于积分的说明 21845049
捐赠科研通 7786165
什么是DOI,文献DOI怎么找? 3435226
关于科研通互助平台的介绍 2559559
邀请新用户注册赠送积分活动 2482157